Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Name: Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
SKU: 2766
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: eduard-parellada, ethnicityrace, health-disparities, illness-characteristics, ipolar-disorder, md, msc, phd

Description

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Divalproex in the Treatment of Bipolar Disorder

Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Related products

Divalproex in the Treatment of Bipolar Disorder

Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening